Bronchial intraepithelial neoplasia/early central airways lung cancer: ACCP evidence-based clinical practice guidelines (2nd edition)

Chest

Volumn 132, Issue 3 SUPPL., 2007, Pages 221S-233S

  Kennedy, Timothy C ^a   McWilliams, Annette ^b   Edell, Eric ^c   Sutedja, Tom ^d   Downie, Gordon ^e   Yung, Rex ^f   Gazdar, Adi ^g   Mathur, Praveen N ^h,i  

^a UNIVERSITY OF COLORADO   (United States)

^b BRITISH COLUMBIA CANCER RESEARCH CENTRE   (Canada)

^c MAYO CLINIC   (United States)

^d VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^e EAST CAROLINA UNIVERSITY   (United States)

^f JOHNS HOPKINS UNIVERSITY   (United States)

^g UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^h INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

ⁱ NONE   (United States)

Author keywords

Angiogenic squamous dysplasia; Autofluorescence bronchoscopy; Carcinoma in situ; Fiberoptic bronchoscopy; Nd YAG; Photodynamic therapy; Radiographically occult lung cancer

Indexed keywords

ARTICLE; BRONCHOSCOPY; BRONCHUS TUMOR; CARCINOMA IN SITU; EVIDENCE BASED MEDICINE; HUMAN; LUNG CANCER; LUNG NON SMALL CELL CANCER; PRACTICE GUIDELINE; PRIORITY JOURNAL; SPUTUM CYTODIAGNOSIS; THORAX RADIOGRAPHY; CLINICAL TRIAL; CYTOLOGY; HOSPITALIZATION; LUNG TUMOR; METHODOLOGY; SENSITIVITY AND SPECIFICITY; SPUTUM;

BRONCHIAL NEOPLASMS; BRONCHOSCOPY; CARCINOMA IN SITU; CARCINOMA, NON-SMALL-CELL LUNG; CLINICAL TRIALS; EVIDENCE-BASED MEDICINE; HUMANS; LUNG NEOPLASMS; RADIOGRAPHY, THORACIC; SENSITIVITY AND SPECIFICITY; SEVERITY OF ILLNESS INDEX; SPUTUM;

EID: 34848858514     PISSN: 00123692     EISSN: None     Source Type: Journal    
DOI: 10.1378/chest.07-1377     Document Type: Article

References (107)

1. Lam SMC, Hung J, LeRiche J, et al. Detection of dysplasia and carcinoma in situ with a lung imaging fluorescence endoscope device. J Thorac Cardiovasc Surg 1993; 105:1035-1040
2. Lam SHJ, Kennedy SM, Leriche JC, et al. Detection of dysplasia and carcinoma in situ by ratio fluorometry. Am Rev Respir Dis 1992; 146:1458-1461
3. Lam SMC, Hung J, LeRiche J, et al. Detection of dysplasia and carcinoma in situ with a lung imaging fluorescence endoscope device. J Thorac Cardiovasc Surg 1992; 105:1035-1040
4. Lam SCM, LeRiche JC, Ikeda N, et al. Early localization of bronchogenic carcinoma. Diagn Ther Endosc 1994; 1:75-78
5. Greenlee RT, Hill-Harmon MB, Murray T, et al. Cancer Statistics 2001. CA Cancer J Clin 2001; 51:15-36
6. Profio AE, Doiron, DR. A feasibility study of the use of fluorescence bronchoscopy for localization of small lung tumors. Phys Med Biol 1977; 22:949-957
7. Lam S, Kennedy TC, Unger M, et al. Localization of bronchial intraepithelial neoplastic lesions by fluorescence bronchoscopy. Chest 1998; 113:696-702
8. Kurie JMLJ, Morice RC, Walsh GL, et al. Autofluorescence bronchoscopy in the detection of squamous metaplasia and dysplasia in current and former smokers. J Natl Cancer Inst 1998; 90:991-995
9. Lam S, McWilliams A. The Role of autofluorescence bronchoscopy in diagnosis of early lung cancer. In: Hirsch FR, Bunn PA Jr, Kato H, et al, eds, IASLC textbook of prevention and early detection of lung cancer. London, UK: Informa Healthcare, 2005
10. Sato M, Sakurada A, Sagawa M, et al. Diagnostic results before and after introduction of autofluorescence bronchoscopy in patients suspected of having lung cancer detected by sputum cytology in lung cancer mass screening. Lung Cancer 2001; 32:247-253
11. Hirsch FR, Prindiville SA, Miller YE, et al. Fluorescence versus white-light bronchoscopy for detection of preneoplastic lesions: a randomized study. J Natl Cancer Inst 2001; 93:1385-1391
12. McWilliams A, Mayo J, MacDonald S, et al. Lung cancer screening: a different paradigm. Am J Respir Crit Care Med 2003; 168:1167-1173
13. Kusunoki Y, Imamura F, Uda H, et al. Early detection of lung cancer with laser-induced fluorescence endoscopy and spectrofluorometry. Chest 2000; 118:1776-1782
14. Kennedy TC, Franklin WA, Prindiville SA, et al. High prevalence of occult endobronchial malignancy in high risk patients with moderate dysplasia. Lung Cancer 2005; 49:187-191
15. Shibuya K, Fujisawa T, Hoshino H, et al. Fluorescence bronchoscopy in the detection of preinvasive bronchial lesions in patients with sputum cytology suspicious or positive for malignancy. Lung Cancer 2001; 32:19-25
16. Haussinger K, Becker H, Stanzel F, et al. Autofluorescence bronchoscopy with white light bronchoscopy compared with white light bronchoscopy alone for the detection of precancerous lesions: a European randomised controlled multicentre trial. Thorax 2005; 60:496-503
17. Herth FJ, Ernst A, Becker HD, Autofluorescence bronchoscopy - a comparison of two systems (LIFE and D-Light). Respiration 2003; 70:395-398
18. Goujon D, Zellweger M, Radu A, et al. In vivo autofluorescence imaging of early cancers in the human tracheobronchial tree with a spectrally optimized system. Biomed Opt J 2003; 8:17-25
19. Helfritzsch H, Junker K, Bartel M, et al. Differentiation of positive autofluorescence bronchoscopy findings by comparative genomic hybridization. Oncol Rep 2002; 9:697-701
20. Pasic A, Vonk-Noordegraaf A, Risse EK, et al. Multiple suspicious lesions detected by autofluorescence bronchoscopy predict malignant development in the bronchial mucosa in high risk patients. Lung Cancer 2003; 41:295-301
21. Chhajed PN, Shibuya K, Hoshino H, et al. A comparison of video and autofluorescence bronchoscopy in patients at high risk of lung cancer. Eur Respir J 2005; 25:951-955
22. Shibuya K, Hoshino H, Chiyo M, et al. Subepithelial vascular patterns in bronchial dysplasias using a high magnification bronchovideoscope. Thorax 2002; 57:902-907
23. Shibuya K, Fujisawa T, Hoshino H, et al. Fluorescence bronchoscopy in the detection of preinvasive bronchial lesions in patients with sputum cytology suspicious or positive for malignancy. Lung Cancer 2001; 32:19-25
24. Shibuya K, Hoshino H, Chiyo M, et al. High magnification bronchovideoscopy combined with narrow band imaging could detect capillary loops of angiogenic squamous dysplasia in heavy smokers at high risk for lung cancer. Thorax 2003; 58:989-995
25. Keith RL, Miller YE, Gemmill RM, et al, Angiogenic squamous dysplasia in bronchi of individuals at high risk for lung cancer. Clin Cancer Res 2000; 6:1616-1625
26. Frost JK, Ball WC Jr, Levin ML, et al. Sputum cytopathology: use and potential in monitoring the workplace environment by screening for biological effects of exposure. J Occup Med 1986; 28:692-703
27. Hirsch FR, Prindiville SA, Miller YE, et al. Fluorescence versus white-light bronchoscopy for detection of preneoplastic lesions: a randomized study. J Natl Cancer Inst 2001; 93:1385-1391
28. Sato MSY, Endo C, Sakurada A, et al. The natural history of radiographically occult bronchogenic squamous cell carcinoma: a retrospective study of overdiagnosis bias. Chest 2004; 126:108-113
29. Risse EK, Vooijs GP, van't Hof MA. Diagnostic significance of "severe dysplasia" in sputum cytology. Acta Cytol 1988; 32:629-634
30. Prindiville SA, Byers T, Hirsch FR, et al. Sputum cytological atypia as a predictor of incident lung cancer in a cohort of heavy smokers with airflow obstruction. Cancer Epidemiol. Biomarkers Prev 2003; 12:987-993
31. McWilliams A, Mayo J, Ahn MI, et al. Lung cancer screening using multi-slice thin-section computed tomography and autofluorescence bronchoscopy. J Thorac Oncol 2006; 1:61-68
32. Lam S, MacAulay C, Hung J, et al. Detection of dysplasia and carcinoma in situ with a lung imaging fluorescence endoscope device. J Thorac Cardiovasc Surg 1993; 105:1035-1040
33. Venmans BJ, van Boxem TJ, Smit EF, et al. Outcome of bronchial carcinoma in situ. Chest 2000; 117:1572-1576
34. Pierard P, Faber J, Hutsebaut J, et al. Synchronous lesions detected by autofluorescence bronchoscopy in patients with high-grade preinvasive lesions and occult invasive squamous cell carcinoma of the proximal airways. Lung Cancer 2004; 46:341-347
35. van Rens MT, Schramel FM, Elbers JR, et al. The clinical value of lung imaging fluorescence endoscopy for detecting synchronous lung cancer. Lung Cancer 2001; 32:13-18
36. Lam S, MacAulay C, LeRiche JC, et al. Early localization of bronchogenic carcinoma. Diagn Ther Endosc 1994; 1:75-78
37. Pierard P, Martin B, Verdebout JM, et al. Fluorescence bronchoscopy in high-risk patients comparison of LIFE and Pentax systems. J Bronchol 2001; 8:254-259
38. Pierard P, Vermylen P, Bosschaerts T, et al. Synchronous roentgenographically occult lung carcinoma in patients with resectable primary lung cancer. Chest 2000; 117:779-785
39. Venmans BJ, van Boxem TJ, Smit EF. Outcome of bronchial carcinoma in situ. Chest 2000; 117:1572-1576
40. Johnson B. Second lung cancers in patients after treatment for an initial lung cancer. J Natl Cancer Inst 1998; 90:1335-1345
41. Nakamura H, Kawasaki N, Hagiwara M, et al. Early hilar lung cancer: risk for multiple lung cancers and clinical outcome. Lung Cancer 2001; 33:51-57
42. Fujimura SS, A., Sagawa M, Saito Y, et al. A therapeutic approach to roentgenographically occult squamous cell carcinoma of the lung. Cancer 2000; 89(suppl):2445-2448
43. Weigel TL, Yousem S, Dacic S, et al. Fluorescence bronchoscopic surveillance after curative surgical resection for non-small-cell lung cancer. Ann Surg Oncol 2000; 7:176-180
44. Weigel TL, Kosco PJ, Dacic S, et al. Postoperative fluorescence bronchoscopic surveillance in non-small cell lung cancer patients. Ann Thorac Surg 2001; 71:967-970
45. Moro-Sibilot D, Jeanmart M, Lantuejoul S, et al. Cigarette smoking, preinvasive bronchial lesions, and autofluorescence bronchoscopy. Chest 2002; 122:1902-1908
46. Sutedja TG, Codrington H, Risse EK, et al. Autofluorescence bronchoscopy improves staging of radiographically occult lung cancer and has an impact on therapeutic strategy. Chest 2001; 120:1327-1332
47. Ikeda N, Hiyoshi T, Kakihana M, et al. Histopathological evaluation of fluorescence bronchoscopy using resected lungs in cases of lung cancer. Lung Cancer 2003; 41:303-309
48. Breuer RH, Pasic A, Smit EF, et al. The natural course of preneoplastic lesions in bronchial epithelium. Clin Cancer Res 2005; 15:537-543
49. Bota S, Auliac JB, Paris C, et al. Follow-up of bronchial precancerous lesions and carcinoma in situ using fluorescence endoscopy. Am J Respir Crit Care Med 2001; 164:1688-1693
50. Lam S, Slivinskas J, McWilliams A, et al. Natural history of premalignant bronchial lesions: implications for chemoprevention. Presented at American Association for Cancer Research Frontiers in Cancer Prevention Research meeting, October 17, 2002
51. Hoshino H, Shibuya K, Chiyo M, et al. Biological features of bronchial squamous dysplasia followed up by autofluorescence bronchoscopy. Lung Cancer 2004; 46:187-196
52. George P, Banerjee A, Read C, et al. Surveillance for the detection of early lung cancer in patients with bronchial dysplasia. Thorax 2007 (in press)
53. Venmans BJ, van Boxem TJ, Smit EF, et al Bronchial intraepithelial neoplastic lesions in head and neck cancer patients: results of autofluorescence bronchoscopy. Ann Otol Rhinol Laryngol 2001; 110:635-638
54. Cortese DA, Pairolero PC, Bergstrahl EJ, et al. Roentgenographically occult lung cancer: a ten-year experience. J Thorac Cardiovasc Surg 1983; 86:373-80
55. Okunaka T, Kato H, Konaka C, et al. Photodynamic therapy for multiple primary bronchogenic carcinoma. Cancer 1991; 68:253-258
56. Imamura S, Kusunoki Y, Takifuji N, et al. Photodynamic therapy and/or external beam radiation therapy for roentgenologically occult lung cancer. Cancer 1994; 73:1608-1614
57. Fujimura S, Sakurada A, Sagawa M, et al. A therapeutic approach to roentgenographically occult squamous cell carcinoma of the lung. Cancer 2000; 89(suppl):2445-2448
58. Deygas N, Froudarakis M, Ozenne G, et al. Cryotherapy in early superficial bronchogenic carcinoma. Chest 2001; 120:26-31
59. Johnson BE. Second lung cancers in patients after treatment for an initial lung cancer. J Natl Cancer Inst 1998; 90:1335-1345
60. Lam S. Photodynamic therapy of lung cancer. Semin Oncol 1994; 21 (suppl):15-19
61. Perol M, Caliandro R, Pommier P, et al. Curative irradiation of limited endobronchial carcinomas with high-dose rate brachytherapy: results of a pilot study. Chest 1997; 111:1417-1423
62. van Boxem TJ, Venmans BJ, Schramel FM, et al. Radiographically occult lung cancer treated with fibreoptic bronchoscopic electrocautery: a pilot study of a simple and inexpensive technique. Eur Respir J 1998; 11:169-172
63. Cavaliere S, Foccoli P, Toninelli C, et al. Nd:Yag laser therapy in lung cancer: an 11-year experience with 2,253 applications in 1,585 patients. J Bronchol 1994; 1:105-111
64. Saito Y, Nagamoto N, Ota S, et al. Results of surgical treatment for roentgenographically occult bronchogenic squamous cell carcinoma. J Thorac Cardiovasc Surg: 1992; 104:401-407
65. Woolner L, Fontana R, Cortese D, et al. Roentgenographically occult lung cancer: pathologic findings and frequency of multicentricity during a 10-year period. Mayo Clin Proc 1994; 59:453-466
66. Konaka C, Hirano T, Kato H, et al. Comparison of endoscopic features of early-stage squamous cell lung cancer and histological findings. Br J Cancer 1999; 80:1435-1439
67. Nakamura H, Kawasaki N, Hagiwara M, et al. Endoscopic evaluation of centrally located early squamous cell carcinoma of the lung. Cancer 2001; 91:1142-1147
68. Miyazu Y, Miyazawa T, Kurimoto N, et al. Endobronchial ultrasonography in the assessment of centrally located early-stage lung cancer before photodynamic therapy. Am J Respir Crit Care Med 2002; 165:832-837
69. Kurimota N, Murayama M, Yoshioka S, et al. Assessment of usefulness of endobronchial ultrasound in determination of depth of tracheobronchial tumor invasion. Chest 1999; 115:1500-1506
70. Hayata Y, Kato H, Konaka C, et al. Photodynamic therapy(PDT) in early stage lung cancer. Lung Cancer 1993; 9:287-294
71. Hayata Y, Kato H, Tanaka C, et al. Hematoporphyrin derivative and laser photoradiation in the treatment of lung cancer. Chest 1982; 81:269-277
72. Hayata Y. Indications of Photodynamic therapy (PDT) in early stage lung cancer [abstract]. Chest 1993; 103(suppl):262S
73. Hayata Y, Kato H, Konaka C, et al. Photoradiation therapy with hematoporphyrin derivative in early and stage 1 lung cancer. Chest 1984; 86:169-77
74. Furuse K, Fukuoka M, Kato H, et al. A prospective phase II study on photodynamic therapy with photofrin II for centrally located early-stage lung cancer: the Japan Lung Cancer Photodynamic Therapy Study Group. J Clin Oncol 1993; 11:1852-1857
75. Kato H, Okunaka T, Shimatani H. Photodynamic therapy for early stage bronchogenic carcinoma. J Clin Laser Med Surg 1996; 14:235-238
76. Kato H. Photodynamic therapy for lung cancer: a review of 19 years' experience. J Photochem Photobiol B Biol 1998; 42:96-99
77. Kato H, Okunaka T, Tsuchida T, et al. Analysis of the cost-effectiveness of photodynamic therapy in early stage lung cancer. Diagn Ther Endosc 1999; 6:9-16
78. Ono R, Ikeda S, Suemasu K. Hematoporphyrin derivative photodynamic therapy in roentgenographically occult carcinoma of the tracheobronchial tree. Cancer 1992; 69:1696-1701
79. Patelli M, Lazzari Agli L, Poletti V, et al. Photodynamic laser therapy for the treatment of early-stage bronchogenic carcinoma. Monaldi Arch Chest Dis 1999; 54: 315-318
80. Sutedja T, Baas P, Stewart F, et al, A pilot study of photodynamic therapy in patients with inoperable non-small cell lung cancer. Eur J Cancer 1992; 28A:1370-1373
81. Sutedja T, Lam S, leRiche J, et al. Response and pattern of failure after photodynamic therapy for intraluminal stage I lung cancer. J Bronchol 1994; 1:295-298
82. Radu A, Grosjean P, Fontolliet C, et al. Photodynamic therapy for 101 early cancers of the upper aerodigestive tract, the esophagus, and the bronchi: a single-institution experience. Diagn Ther Endosc 1999; 5:145-154
83. Lam S, Haussinger K, Leroy M, et al. Photodynamic therapy (PDT) with Photofrin, a treatment with curative potential for early stage superficial lung cancer [abstract]. In: 34th Annual Meeting of the American Society of Clinical Oncology. Los Angeles, CA, 1998
84. Edell ES, Cortese DA, McDougall JC. Ancillary therapies in the management of lung cancer: photodynamic therapy, laser therapy, and endobronchial prosthetic devices. Mayo Clin Proc 1993; 68: 685-690
85. Edell ES, Cortese DA. Bronchoscopic phototherapy with hematoporphyrin derivative for treatment of localized bronchogenic carcinoma: a 5-year experience. Mayo Clin Proc 1987; 62: 8-14
86. Cortese DA, Kinsey JH. Hematoporphyrin derivative phototherapy in the treatment of bronchogenic carcinoma. Chest 1984; 86:8-13
87. Edell ES, Cortese DA, Bronchoscopic localization and treatment of occult lung cancer. Chest 1989; 96:919-921
88. Edell ES, Cortese DA Photodynamic therapy in the management of early superficial squamous cell carcinoma as an alternative to surgical resection. Chest 1992; 102: 1319-1322
89. Edell E, Cortese DA. Photodynamic therapy: treatment of early stage lung cancer; results and follow-up. Excerpta Medica International Congress series. 1990; 894:205-210
90. Cortese DA, Edell ES, Kinsey JH. Photodynamic therapy for early stage squamous cell carcinoma of the lung. Mayo Clin Proc 1997; 72:595-602
91. Vonk-Noordegraaf A, Postmus PE, Sutedja TG. Bronchoscopic treatment of patients with intraluminal microinvasive radiographically occult lung cancer not eligible for surgical resection: a follow-up study. Lung Cancer 2003; 39:49-53
92. Marsiglia H, Baldyrou P, Lartigau E, et al. High-dose-rate brachytherapy as sole modality for early-stage endobronchial carcinoma. Int J Radiat Oncol Biol Phys 2000; 47: 665-672
93. Lam S. Bronchoscopic, photodynamic, and laser diagnosis and therapy of lung neoplasms. Curr Opin Pulm Med 1996; 2:271-276
94. Lam S, MacAulay C, LeRiche JC, et al. Early localization of bronchogenic carcinoma. Diagn Ther Endosc 1994; 1:75-78
95. Weigel TPK, Dacic S, Yousem S, et al. Fluorescence bronchoscopic surveillance in patients with a history of non-small cell lung cancer,. Diagn Ther Endosc 1999; 6:1-7
96. Kurie JM, Lee JS, Morice RC, et al. Autofluorescence bronchoscopy in the detection of squamous metaplasia and dysplasia in current and former smokers. J Natl Cancer Inst 1998; 90:991-995
97. Kennedy TFH, Miller Y, Prindiville S, et al. A randomized study of fluorescence bronchoscopy versus white light bronchoscopy for early detection of lung cancer in high risk patients [editorial]. Lung Cancer 2000; 29:244
98. Venmans BJW, van Boxem AJM, Smit EF, et al. Early detection of preinvasive lesions in high-risk patients: a comparison of conventional flexible and fluorescence bronchoscopy. J Bronchology 1998; 5:280-283
99. Venmans BTVB, Smit EF, Postmus P, et al. Results of two years experience with fluorescence bronchoscopy in detection of preinvasive bronchial neoplasia. Diagn Ther Endosc 1999; 5:77-84
100. Vermylen PCR, Pierard P, Verhest A, et al. Detection of preneoplastic lesions with fluorescence bronchoscopy [abstract]. Eur Respir J 1997 10:425S
101. Khanavkhar B. Autofluorescence (LIFE-Lung) bronchoscopy: results of 368 examinations and review of international experience. In: Proceedings of ERS-Congress. Lausanne, Switzerland: European Respiratory Society, 1998
102. Metwally MBK, Muti A, Marek W, et al. Improving early lung cancer detection and localization by automated image cytometry and autofluoreseence bronchoscopy [abstract]. Eur Respir J 2000; Suppl 31:16
103. Thiberville LPS, Diaz-Gimenez P, Sutedja T, et al. A multicenter European study using the lung fluorescence endoscopy system to detect precancerous lesions of the bronchus in high risk individuals [abstract]. Eur Respir J 1999; Suppl 30:14
104. van Rens MT, Schramel FM, Elbers JR, et al. The clinical value of lung imaging fluorescence endoscopy for detecting synchronous lung cancer. Lung Cancer 2001; 32: 13-18
105. Yokomise H, Yanagihara K, Fukuse T, et al. Clinical experience with lung-imaging fluorescence endoscope (LIFE) in patients with lung cancer. J Bronchology 1997; 4:205-208
106. Ikeda, N, Honda H, Katsumi T, et al. Early detection of bronchial lesions using lung imaging fluorescence endoscope,. Diagn Ther Endosc 1999; 5:85-90
107. Lee F, Ng A, Weng Y. Early detection of lung cancer with the LIFE laser [abstract]. Chest 1995; 108(suppl):115